Ambit Inc.’s Post

Unlock the Power of Personalized Medicine with PGx Testing FirmaLab Bio-Diagnostics 1️⃣ Optimized Treatments: PGx ensures medications are tailored to a patient’s genetic profile, minimizing trial-and-error prescribing. 2️⃣ Improved Patient Outcomes: Reduce adverse drug reactions and enhance treatment effectiveness, leading to better patient care. 3️⃣ Cost Efficiency: Avoid unnecessary prescriptions and hospitalizations with data-driven medication decisions. PGx: The future of precision medicine is here. Let’s help patients get the right drug at the right dose the first time. #Pharmacogenomics #PGxTesting #PersonalizedMedicine #PrecisionMedicine #HealthcareInnovation #PatientCare #Genomics #FutureOfHealthcare #DivineConceptsManagement

Understanding Pharmacogenomic Testing: A Guide for BC Patients 🧬 Did you know your genes can affect how medications work for you? Pharmacogenomic (PGx) testing helps healthcare providers understand how your body processes medications, based on your unique genetic makeup. This information can help: 🍃Reduce unwanted side effects 🍃Find the right dosage 🍃Choose a medication well suited to you Learn how PGx testing can lead to more personalized and effective treatments with our new handout designed for BC patients. Take control of your health by learning how your genes can guide your treatment plan! 👉 Download the Patient Handout:https://lnkd.in/gMc4Mh3s #PersonalizedMedicine #Pharmacogenomics #GenomeBC #HealthcareInnovation #BCHealth

𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐍𝐞𝐰𝐬 𝐢𝐧 𝐋𝐮𝐩𝐮𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭! At the ACR Convergence 2024, UCB and Biogen unveiled promising Phase 3 data from the PHOENYCS GO study on dapirolizumab pegol (DZP). This innovative Fc-free anti-CD40L therapy showed a 14.6% higher response rate in reducing disease activity in patients with moderate-to-severe systemic lupus erythematosus (SLE). 🔗 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 https://lnkd.in/gdwjSxyJ #lupusawareness #clinicaltrials #healthcareinnovation #biotech #autoimmunedisease #medicalresearch #patientcare #healthtech #drugdevelopment #chronicillness #researchnews

Today, Rare Disease Day 2024, represents a global effort towards awareness and equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease. 🧬 Rare diseases are not so rare: an estimated one in 20 people have a rare disease, and two out of 10 people know someone who has one. Accordingly, rare diseases have emerged as a global public health priority and have been at the forefront of biomedical research in recent years. 🩺 Ipsos supports the development and monitors the evolution of treatments in rare diseases – and we thank the rare disease community for their participation in our research programs! #rarediseaseday #raredisease #biotech #pharmaceutical #digitalhealth #IpsosRareDiseaseCOE

Interesting to see developments in the use of CAR-T for autoimmune diseases.

Compassionate use programs play a crucial, yet often underappreciated, role in drug development; providing patients, particularly those with rare diseases, access to potentially life-saving therapies that may positively impact the trajectory of their health outcomes.   We're thrilled to publish, in partnership with WEP Clinical and Ana Paula Tediosi, this two-part series on compassionate use programs and the meaningful benefits in the development of a potential treatment for multiple forms of insulin receptor mediated hypoglycemia. https://bit.ly/4eXiL0O #clinicaltrials #clinicalresearch #raredisease #hypoglycemiaawarenessweek

The Rise in awareness about early-stage disease diagnosis and government screening programs to lower the incidence rate and mortality are anticipated to burgeon the growth of the #point of #care #diagnostics market over the forecast years. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞: (https://lnkd.in/gKfCzywY) Abbott, Koninklijke Kentalis, BD, Mologico GmbH, Johnson & Johnson, Sinocare Inc., Roche Diagnostics UK & Ireland, Nova Biomedical, Instrumentation Limited, Palakkad, AccuBioTech Co., Ltd., Alpha Laboratories Ltd., EKF Diagnostics, Spectral Medical Inc., OraSure Technologies, SEKISUI Diagnostics, Trinity Biotech, QuidelOrtho, Trividia Health, Inc. , Nova Biomedical, Werfen, Siemens Healthcare FZ LLC , bioMérieux #marketanalysis #marketgrowth #marketdata #marketsize #marketshare #markettrends #marketreport #marketoutlook #marketoverview #drivers #marketresearchreport #marketsegmentation #marketsummary #restraints #researchanddevelopment #researchmethods #researchreport #marketdemand

Excellent read highlighting the significance of safety monitoring in rare disease trials. Unlike chronic more prevalent conditions, rare diseases typically require a minimum long-term safety database of 100 patients, compared to 1000 for chronic conditions. The HEALEY ALS Platform Trial, an adaptive clinical Phase 2/3 trial, exemplifies effective safety monitoring and trial adaptability for optimal outcomes. Platform trials offer numerous benefits, and PharmAust's recent selection for the HEALEY ALS Platform Trial promises exciting progress updates in collaboration with Mass General. #PharmAust #RareDiseases #NeurodegenerativeDiseases #Biotech #HEALEYALSTrial

🌟 Exciting News! 🌟 I'm happy to share my latest editorial titled "Advances in Liquid Biopsy Research for Disease Detection, Diagnosis, and Treatment and What the Future May Hold". 📝💡 In this editorial, I delve into the latest innovations shaping the landscape of liquid biopsy research. 💉 From early disease detection to personalized treatment strategies, discover how liquid biopsies are revolutionizing healthcare. 🩺✨ Click the link below to read more! 👇 #LiquidBiopsy #Research #HealthcareInnovation #FutureMedicine https://lnkd.in/ebKUeWaq

🧬 Personalized Medicine Through DNA Did you know your genes can influence how you respond to medications? Pharmacogenomics tailors your treatment plan for better outcomes with fewer side effects! 💡 Key Points: 💊 How pharmacogenomics improves drug efficacy  💊 Predicting and preventing adverse reactions  💊 The future of personalized healthcare Take charge of your health with DNA-driven treatments: https://lnkd.in/d79qQrT5 #Pharmacogenomics #PersonalizedMedicine #DNATesting #PrecisionMedicine #HealthcareInnovation #GeneticsInMedicine #FutureOfHealthcare